Regeneron Pharmaceuticals Stock May Be Worth Buying Again - Rating Upgrade

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) is a Tarrytown, NY-based biotech company, founded in 1988, that has become a leading player in the specific area of a blood vessel inhibitor known as the VEGF-trap. TheyI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I believe the key to creati ...